earticle

논문검색

Poster 06

Anticancer Activity of a Water-soluble Polysaccharide Isolated from Korean Capsosiphon fulvescens

초록

영어

Seaweed extracts have been reported for their diverse biological and pharmacological activities including immunomodulating, anticoagulaning, anticancer activities, etc. Capsosiphon fulvescens (CF) is a green alga that is widely ditributed in the Southern coastal area of Korea. Crude polysaccharides were obtained from the CF collected at a coastal area of Wando, Korea by extraction in acidic condition (0.01 N HCl) and 75% ethanol precipitaion. After removal of alginate by CaCl2 precipitaion, it was futher purified by DEAE-cellulose column chromatography and its chemical components and anticancer activity was determined. Monosaccharide composition analysis by TLC and HPEAC-PAD showed that this polysaccharide consist of Rha, Man and Xyl as the major neutral sugars, with the mole ratios of 4.1:1.0:3.7, respectively, suggesting that it is a mannoxylorhamnan type polysaccharide. This polysaccharide (1 mg/ml) was shown to effectively scavenge nitrite up to 40% at pH 3. The effects of this polysccharide on the cell viability of 4 cancer cell types, human prostate cancer cell (PC-3), human lung cancer cell (A-549), human colon cancer cell (HT-29), and human gastric cancer cell (MK-N-45), were evaluated by MTT assay. It showed most significant cytotoxicity against HT-29 cells among cancer cell lines tested. This polysaccharide significantly induced the cleavage of PARP, caspase 8 and caspase 9, and also enhanced the phosphorylation of p38 in a dose-dependant manner. However, it was shown to reduce the AKT phosphorylation and mitochondrial membrane charge causing mitochondrial dysfunction. Taken collectively, these results demonstated that a watersoluble polysaccharide isolated from the sporophyll of Korean Capsosiphon fulvescens inhibits proliferation of HT-29 cells by activation of apoptotic pathway, suggesting that this polysaccharide can be a good candidate for the development of a potent anti-cancer agent against human colon cancer.

저자정보

  • Ji Won Choi Department of Biotechnology, The Catholic University of Korea, Bucheon, Gyeonggi-do 420-743, Korea
  • Jisun Lee Department of Biotechnology, The Catholic University of Korea, Bucheon, Gyeonggi-do 420-743, Korea
  • Doo Jin Choi Department of Biotechnology, The Catholic University of Korea, Bucheon, Gyeonggi-do 420-743, Korea
  • Chang Won Lee Department of Biotechnology, The Catholic University of Korea, Bucheon, Gyeonggi-do 420-743, Korea
  • Seul Lee Department of Biotechnology, The Catholic University of Korea, Bucheon, Gyeonggi-do 420-743, Korea
  • Yong Il Park Department of Biotechnology, The Catholic University of Korea, Bucheon, Gyeonggi-do 420-743, Korea

참고문헌

자료제공 : 네이버학술정보

    함께 이용한 논문

      ※ 원문제공기관과의 협약기간이 종료되어 열람이 제한될 수 있습니다.

      0개의 논문이 장바구니에 담겼습니다.